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Abstract
Objectives To evaluate the additional value of computer-
aided detection (CAD) in breast MRI by assessing radiol-
ogists’ accuracy in discriminating benign from malignant
breast lesions.
Methods A literature search was performed with inclusion
of relevant studies using a commercially available CAD
system with automatic colour mapping. Two independent
researchers assessed the quality of the studies. The accuracy
of the radiologists’ performance with and without CAD was
presented as pooled sensitivity and specificity.
Results Of 587 articles, 10 met the inclusion criteria, all of
good methodological quality. Experienced radiologists
reached comparable pooled sensitivity and specificity
before and after using CAD (sensitivity: without CAD:
89%; 95% CI: 78–94%, with CAD: 89%; 95%CI: 81–94%)
(specificity: without CAD: 86%; 95% CI: 79–91%, with
CAD: 82%; 95% CI: 76–87%). For residents the pooled
sensitivity increased from 72% (95% CI: 62–81%) without
CAD to 89% (95% CI: 80–94%) with CAD, however, not
significantly. Concerning specificity, the results were
similar (without CAD: 79%; 95% CI: 69–86%, with
CAD: 78%; 95% CI: 69–84%).
Conclusions CAD in breast MRI has little influence on the
sensitivity and specificity of experienced radiologists and
therefore their interpretation remains essential. However,
residents or inexperienced radiologists seem to benefit from
CAD concerning breast MRI evaluation.
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Introduction
Dynamic contrast-enhanced Magnetic Resonance Imaging
(MRI) is increasingly used to evaluate pathological features
of the breast. Applications for MRI of the breast include
diagnostic and screening indications [1–6]. Image analysis
is based on the enhancement pattern of lesions in dynamic
breast MRI and on morphological characteristics [7–9].
Using those two criteria for the interpretation of the images,
breast MRI has a very high sensitivity, which usually
exceeds 90% [10–12] and a negative breast MRI shows a
sufficient high negative predictive value (NPV) (97%) to
safely rule out malignancy [13–15]. However, breast MRI
has several limitations, the overall reported specificity
varies between 67% and 72%, which therefore results in a
high number of false-positive results [10, 12, 16]. Further-
more, MRI requires significant time for image acquisition,
processing and interpretation [17, 18]. In order to try to
overcome those limitations, Computer Aided Detection
(CAD) programs for MR imaging of the breast have been
developed [18]. In general, CAD software was developed to
identify suspect features on the image and bring them to the
attention of the radiologist, in order to decrease false-
negative readings [19]. However, in breast MRI, most
lesions were regarded as having already been detected by
the radiologist. Therefore, the primary aim to develop CAD
for breast MRI was not to identify lesions, but to assist the
radiologist in determining which lesions are benign and
which are malignant.
Computer-aided detection systems automate many pro-
cessing and analysis functions, which would normally have
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radiologists. The automated kinetic assessment of CAD
generates a colour-coding based on the signal intensity
voxel changes during the enhancement of the breast tissue.
This provides an easier way of interpreting the patterns of
contrast enhancement (persistent, plateau and washout
enhancement) across a series of images, which may help
identify lesions and their likelihood of being malignant.
The implementation of CAD software may improve the
accuracy of breast MRI by reducing the number of false-
positive diagnoses and by shortening the time needed to
interpret breast MRI images [17, 18, 20, 21]. Furthermore,
a state of the art CAD system should automatically identify
(almost) all non-calcified lesions suspected of malignancy
at mammography. This is reflected by a very high
sensitivity and NPV for these non-calcified breast lesions.
The purpose of this systematic review and meta-analysis
is to assess the radiologists’ accuracy in discriminating
benign from malignant breast lesions regarding breast MRI
with and without CAD implementation in terms of
sensitivity and specificity.
Materials and methods
Search strategy
A computerised search was performed to identify all
relevant studies in Medline and Embase up to 2010. The
following search terms were used in Medline: “Diagnosis,
Computer-Assisted” [Mesh term] OR “computer-aided-
diagnosis” [Text Word] OR “computer-aided-detection”
[Text Word] OR “computer-aided” [Text Word] OR
“CAD” [Text Word] OR “three-time-point method” [Text
Word] AND “Magnetic Resonance Imaging” [Mesh term]
OR “Magnetic Resonance Imaging” [Text Word] OR
“MRI” [Text Word] OR “MR imaging” [Text Word] AND
“Breast Neoplasms” [Mesh term] OR “breast cancer” [Text
Word] OR “mamma carcinoma” [Text Word] OR “malig-
nant breast lesions” [Text Word] AND (“Sensitivity and
Specificity” [Mesh term] OR “specificity OR sensitivity”
[Text Word]. In Embase the same strategy was used. All
languages were considered.
Eligibility criteria and study selection
We searched for studies assessing the value of CAD for a
radiologist in the discrimination between benign and
malignant breast lesions with MRI. Studies were included
if the following inclusion criteria were met: (1) all patients
had undergone breast MRI; (2) a commercially available
CAD system was used; (3) the study population had benign
and malignant breast lesions; (4) accuracy, sensitivity,
specificity, positive predictive value and/or negative pre-
dictive value was/were measured or could be derived, and
(5) studies had to be published with original data in peer-
reviewed journals. Studies in which an institution-specific
CAD system was used were excluded, as well as reviews,
editorials and case reports.
Two researchers (MDD, MCJW) independently selected
relevant studies based on title and abstract or full article.
Any discrepancies concerning the study selection were
resolved by discussion of the full article. The complete
search yielded 587 studies. 519 out of 587 studies were
excluded based on the title. After removing duplicates (n=
12), 56 studies were screened on title and abstract. Twenty-
nine studies did not meet the inclusion criteria (technical
article (n=20), overview (n=8) and case report (n=1)).
From the remaining 27 studies the full article was reviewed.
Seventeen studies were excluded because CAD was an
institution-specific CAD system. Ten studies [20–29]
fulfilled our inclusion criteria (Fig. 1). Eight studies were
in the English language [20–24, 26, 27, 29]; the other 2
were in the German Language [25, 28].
Data collection and quality assessment
The following study descriptives were extracted: population
descriptives (age, number of patients, number of benign and
malignant lesions), study design, type of MRI used, type of
CAD software used, minimum threshold enhancement
used, number of radiologists that assessed the MR images
with and without the use of CAD and diagnostic accuracy
numbers (true-positives, false-positives, true-negatives and
false-negatives).
Study quality was assessed independently by the same
two observers using the QUADAS tool [30, 31], disagree-
ment was resolved by arbitration. This evidence-based tool
is developed specifically to assess the quality of diagnostic
accuracy studies and includes 14 quality items. The 14
items can be scored as “yes”, “no” or “unclear”. The total
score can range from 0 to 14, in which 14 is the maximum
attainable score.
Statistical analysis
The performance of the radiologist in distinguishing breast
lesions on MRI with and without the implementation of
CAD was assessed. Besides the use of CAD, comparisons
were made between radiologists with experience in imaging
assessment and residents or radiologists with no or minor
experience. Primary outcome was sensitivity and specificity
at tumour level. Pooling of data was performed within the
bivariate mixed-effects binary regression modelling frame-
work. Model specification, estimation and prediction were
carried out with xtmelogit in STATA. Using the model
Eur Radiol (2011) 21:1600–1608 1601summary sensitivity and specificity were calculated, and a
summary ROC curve was drawn (with AUC and confi-
dence intervals). A forest plot was generated containing the
individual study sensitivities and specificities with 95%
confidence intervals (CI) and the pooled sensitivity and
specificity estimates.
A test for heterogeneity was applied, using the I
2 statistic
[32]. This statistic calculates the percentage of total
variation across studies that can be attributed to inter-
study heterogeneity, ranging from 0 (no heterogeneity) to
100% (all variance due to heterogeneity). The presence of
publication bias was visually assessed by producing a
funnel plot. In STATA linear regression was performed of
log odds ratios on the inverse root of effective sample sizes
as a test for funnel plot asymmetry. The log odds ratios are
defined as the log transformed diagnostic odds ratios,
which are needed for the performance of linear regression.
Publication bias was considered present if there was a
significant non-zero slope coefficient, (p<0.10), suggesting
that only the small studies reporting a high sensitivity with
CAD had been published, whereas the small studies
reporting a lower sensitivity had not been published. Data
were analysed in SPSS 16.0 (SPSS, Chicago, IL, USA),
Meta Disc [33] and STATA SE version 11.0 (STATA,
College Station, TX, USA).
Results
Study descriptives
The 10 studies included a total of 895 patients (range 29–
329) with a total of 1264 breast lesions (range 33–469) of
which 606 were classified as malignant (range 9–279) and
658 as benign (range 22–190) [20–29].
In 5 [23, 24, 26–28] studies a selection was made of
patients with suspect findings based on mammography and
ultrasound examinations. In the other 5 studies [20–22, 25,
29] patients with a suspect lesion on MRI were included. One
of these 5 studies retrospectively searched the database of an
ongoing MRI screening study of patients at high risk of breast
cancer for BIRADS 3–5 lesions that were detected with MRI
[22], and 2 studies included lesions that were not palpable
and were not visible on mammography or ultrasound [20,
21]. In all 10 studies histology was used as the gold standard.
In 4 studies a follow-up MRI after 6 or 24 months was
performed [23, 25, 28, 29]; in the case of positive findings
biopsy provided further histological assessment.
Mean study quality was 12.6, ranging from 10 to 14. Four
studies were of maximum quality (Table 1)[ 20, 21, 26, 27].
CAD systems
In all 10 studies the CAD systems (CADstream, DynaCAD,
Fulltime point, 3-Time-Point Method and CAD-Gaea) incor-
porated precontrast medium (unenhanced) images and 2
(immediate and delayed) or all postcontrast medium (en-
hanced) images. The CAD systems compared pixel intensity
valuesontheprecontrastmediumandimmediatedpostcontrast
medium series. If a pixel value increased above a user-
specified minimum enhancement threshold, such as a 50 or
100% increase in enhancement, the pixel was regarded as
meetingthresholdenhancement.Onceapixelwasidentifiedas
enhancing above the established threshold, the CAD systems
compared pixel signal intensity values on the immediate and
delayed postcontrast medium series to indicate washout
enhancement,plateauenhancementorpersistentenhancement.
Aspecificcolourorcolourintensitywasassignedtoeachpixel
for different types of tissue enhancement. The end result of all
CAD systems was a colour overlay on each MRI slice
Search result: n= 587 
(319 Pubmed; 268 Embase) 
Excluded based on title: n= 519 
Papers retrieved for more 
detailed evaluation 
(n=56) 
Selection based on full paper 
(n=27) 
Excluded (n=29) 
- technical paper: 20 
- overview: 8 
- case report: 1 
Excluded (n=17) 
- Institution-specific CAD systems 
Included in the review 
(n=10) 
12 duplicates
Fig. 1 Flow chart of search results, with reasons for exclusion and the
total number of studies included
1602 Eur Radiol (2011) 21:1600–1608indicating regions of significant enhancement and providing
details about enhancement type and extent.
CAD threshold enhancement
Six [20–24, 27] studies analysed the presence or absence of
“threshold enhancement” at different minimum thresholds.
Lehman et al. [20], Williams et al. [21] and Meeuwis et al.
[27] used the CAD system CADstream. The sensitivity at
the minimum thresholds of 50%, 80% and 100% remained
the same. The specificity increased at higher minimum
thresholds. The study by Meeuwis et al. [27] showed a
higher specificity than the other two studies. In the studies
by Baltzer et al. [23, 24] DynaCAD was used. In these
studies, the sensitivity decreased and the specificity
increased at higher minimum thresholds. CAD-Gaea [22]
had the same results as DynaCAD with respect to
sensitivity and specificity, although CAD-Gaea had a lower
level of specificity. Meeuwis et al. [27], using CADstream,
reported the highest sensitivity and specificity (Table 2).
Table 1 Study characteristics of the 10 included studies (SD standard deviation, NR not reported, P prospective, R retrospective, c consecutive,
TB tumour-based)
Study (author, ref.,
year of publication)
No. of
patients
Study
design
Quality
score
Mean age
(SD or range)
No. of
lesions
No. of
malignant
No. of
benign
Type of
analysis
MRI CAD
system
Arazi-Kleinman [22]
2009
53 R, c 13 47 (26–68) 56 22 34 TB 1.5T CAD-Gaea
Meeuwis [27] 2009 65 R, c 14 49 (29–71) 71 49 22 TB 3.0T CADstream
Baltzer [23] 2009 51 R, c 12 51 (13) 90 46 44 TB 1.5T DynaCAD
Baltzer [24] 2009 329 P, c 13 53 (15–83) 469 279 190 TB 1.5T DynaCAD
Veltman [29] 2009 NR R,c 11 NR 52 25 27 TB 1.5T 3-Time-Point
Renz [28] 2008 48 P, c 11 51 (31) 88 43 45 TB 1.5T DynaCAD
Full-time
Point
Hauth [25] 2008 137 R 10 NR 183 61 122 TB 1.5T 3-Time-Point
Williams [21] 2006 126 R, c 14 52 (27–86) 154 41 113 TB 1.5T CADstream
Lehman [20] 2005 29 R, c 14 NR 33 9 24 TB 1.5T CADstream
Kelcz [26] 2002 57 P, c 14 52 (31–80) 68 31 37 TB 1.5T 3-Time-Point
Table 2 The sensitivity and specificity of a CAD system using the presence or absence of lesion enhancement at the user-specified minimum
thresholds
Study MRI CAD System No. of lesions MRI assessed
by using
Sensitivity Specificity
Arazi-Kleinman [22] 1.5T CAD-Gaea 56 Threshold 50% 100% 0%
Threshold 80% 95.5% 14.7%
Threshold 100% 72.7% 44.1%
Baltzer [23] 1.5T DynaCAD 90 Threshold < 50% 100% 0%
Threshold 50%–100% 84.8% 45.4%
Threshold > 100% 52.1% 72.7%
Baltzer [24] 1.5T DynaCAD 469 Threshold < 50% 100% 0%
Threshold 50%–100% 86.4% 53.2%
Threshold > 100% 52.0% 83.7%
Meeuwis [27] 3.0T CADstream 71 Threshold 50% 97.9% 86.4%
Threshold 100% 97.9% 90.9%
Williams [21] 1.5T CADstream 154 Threshold 50% 92.7% 8.9%
Threshold 100% 92.7% 23.0%
Lehman [20] 1.5T CADstream 33 Threshold 50% 100% 25.0%
Threshold 80% 100% 33.0%
Threshold 100% 100% 50.0%
Eur Radiol (2011) 21:1600–1608 1603Radiologist with or without CAD
In 8 out of 10 studies [22–29] the sensitivity and specificity
of the radiologist or resident in assessing MR images with
the use of CAD were measured (Table 3). The enhancement
thresholds used were set up individually according to the
radiologist’s preference. Furthermore, in 4 [24, 27–29] out
of these 8 studies the sensitivity and specificity of the
radiologist or resident was also calculated without the use
CAD. In these four studies the radiologists or residents
assessed the MR images as visual evaluation of contrast
enhancement or by making a manual curve analysis by
using the region of interest (ROI) method [24, 27–29]. The
pooled sensitivity and specificity of radiologists and
residents assessing breast lesions on MRI without the
implementation of CAD was 82% (95% CI: 72–90%) and
81% (95% CI: 74–87%), respectively. With CAD imple-
mentation they attained higher sensitivity scores (sensi-
tivity: 89%, 95% CI: 83–93%; specificity: 81%, 95% CI:
76–85%) (Fig. 2). The sROC curve showed an AUC of
0.89 (Fig. 3). In 3 studies differentiation was made
between radiologists with experience and residents with
no or minimal experience [27–29] .T h ee x p e r i e n c eo f
those radiologists varied from 5 to 15 years (or > 500
MRIs). Residents had no more than 6 months (or < 50
MRIs) breast MRI experience. After stratification, the
experienced radiologists showed a comparable pooled
sensitivity of 89% with (95% CI: 81–94%) and without
(sensitivity: 89%; 95% CI: 78–94%) CAD implementa-
tion. The pooled specificity of 86% (95% CI: 79–91%)
Table 3 The performance of radiologists and residents in breast MRI diagnosis in terms of sensitivity and specificity with and without the use of
a CAD system, specified for type of CAD and MRI system, number of lesions, and experience (RAD radiologist RES resident)
Study MRI CAD system No. of lesions MRI assessed by using Experience Sensitivity Specificity
Arazi-Kleinman [22] 1.5T CAD-Gaea 56 CAD+RAD 5 years 73.0% 56.0%
Meeuwis [27] 3.0T CADstream 71 CAD+RAD1 > 5 years 88.5% 75.0%
71 CAD+RAD2 > 5 years 92.3% 87.5%
71 CAD+RES1 6 months 88.5% 93.8%
71 CAD+RES2 0 months 84.6% 81.3%
42 RAD (manual)
a 84.6% 68.8%
Baltzer [23] 1.5T DynaCAD 90 CAD+RAD 1–3 years 80.4% 72.7%
Baltzer [24] 1.5T DynaCAD 469 CAD+RAD >300 MRIs 78.8% 73.2%
469 RAD (manual)
a 75.3% 76.3%
469 RAD (visual)
b 72.4% 77.4%
Renz [28] 1.5T DynaCAD 88 CAD+RAD1 > 500 MRIs 100% 86.7%
88 CAD+RAD2 > 500 MRIs 95.3% 93.3%
88 CAD+RAD3 < 50 MRIs 90.7% 73.3%
Full-time point 88 CAD+RAD1 100% 84.4%
88 CAD+RAD2 95.3% 91.1%
88 CAD+RAD3 100% 66.7%
88 RAD1 (visual)
b 97.7% 84.4%
88 RAD2 (visual)
b 93.0% 93.3%
88 RAD3 (visual)
b 86.0% 77.8%
Veltman [29] 1.5T 3-Time-point 52 CAD+RES1 0 months 80% 78%
CAD+RES2 3 months 80% 81%
CAD+RES3 5 years 80% 85%
CAD+RAD4 15 years 80% 78%
RES1 (manual)
a 68% 67%
RES2 (manual)
a 52% 81%
RES3 (manual)
a 72% 85%
RAD4 (manual)
a 84% 85%
Hauth [25] 1.5T 3-Time-point 183 CAD+RAD 3 years 60.7% 83.6%
Kelcz [26] 1.5T 3-Time-point 68 CAD+RAD >500 MRIs 87.0% 84.0%
a Manual: manual curve analysis by using the region of interest (ROI) method
b Visual: visual evaluation of contrast enhancement
1604 Eur Radiol (2011) 21:1600–1608decreased to 82% (95% CI: 76–87%) with CAD. Resi-
dents or radiologists with less experience showed a pooled
sensitivity of 72% (95% CI: 62–81%) and a pooled
specificity of 79% (95% CI: 69–86%) when assessing
breast lesions on MRI without CAD. With the use of
CAD, their sensitivity increased to 89% (95% CI: 80–
94%), whereas their specificity remained comparable
(specificity: 78%; 95% CI: 69–84%) (Table 4).
Analyses of heterogeneity
Moderate to substantial heterogeneity was observed among
the eight studies exploring the sensitivity and specificity of
radiologists assessing MR images with and without the
implementation of CAD (sensitivity: no CAD: I
2: 78%, p<
0.0001, with CAD: I
2: 80%, p<0.0001; specificity: no
CAD: I
2: 46%, p=0.007, with CAD: I
2: 55%, p=0.002).
After stratification of radiologists with experience and
residents with no or minimal experience, heterogeneity
did not change for experienced radiologists (sensitivity: no
CAD: I
2: 79%, p<0.0001, with CAD: I
2: 83%, p<0.0001),
and residents (sensitivity: no CAD: I
2: 79%, p=0.009; with
CAD: I
2: 64%, p=0.02). Concerning specificity, heteroge-
neity dropped to low to moderate (radiologists without
CAD: specificity: I
2: 56%, p=0.04, radiologists with CAD:
specificity: I
2: 62%, p=0.01; residents without CAD:
specificity:I
2:3 3 % ,p=0.22; residents with CAD: specificity:
I
2:2 4 % ,p=0.26). Because of heterogeneity and possible
Fig. 2 Funnel plot with log odds ratios on the inverse root of effective
sample sizes for visualisation of publication bias
Fig. 3 Summary ROC curve regarding the studies of radiologists and residents using a CAD system
Eur Radiol (2011) 21:1600–1608 1605unmeasured variance at the study level a random-effects
model was used to obtain all pooled estimates, as this model
interprets the available data with more caution and uses
broad confidence intervals.
Assessment publication bias
A non-significant non-zero slope coefficient (p-value=
0.16) indicated that there was no evidence of publication
bias (Fig. 4). This suggests that we most likely did not miss
studies with a negative outcome.
Discussion
This meta-analysis shows that the pooled sensitivity and
specificity of the experienced radiologist for the assessment
of breast lesions with MRI remains comparable with the
implementation of CAD. Residents or radiologists with less
experience seem to attain a higher sensitivity with CAD
implementation, although not significant.
All selected studies were of high quality, so it is likely that
the quality of the studies did not have a significant impact on
the results of the meta-analysis. Furthermore, there was no
Fig. 4 Forest plot of pooled sensitivity and specificity of radiologists and residents assessing breast lesions on MRI with the use of a CAD system
Table 4 Results of pooled sensitivity and specificity (95% CI) of the radiologist in assessing breast lesions on MRI with and without the use of a
CAD system in general, stratified for experienced radiologists and residents with no or less experience (RANDOM effects model)
Outcome or subgroup Studies
a Sensitivity (95% CI) Specificity (95% CI)
Radiologist no CAD, general 4
b 82% (72%–90%) 81% (74%–87%)
Radiologist with CAD, general 8
c 89% (83%–93%) 81% (76%–85%)
Experienced radiologist no CAD 4
b 89% (78%–94%) 86% (79%–91%)
Experienced radiologist with CAD 8
c 89% (81%–94%) 82% (76%–87%)
Resident no CAD 3
d 72% (62%–81%) 79% (69%–86%)
Resident with CAD 3
d 89% (80%–94%) 78% (69%–84%)
a In studies in which more than one radiologist/resident (blinded) assessed the images, the pooled calculation was based on all relevant radiologists in that
study
b Meeuwis [27], Baltzer [24], Renz [28], Veltman [29]
c Arazi-Kleinmann [22] Meeuwis [27], Baltzer [23], Baltzer [24], Renz [28], Veltman [29], Hauth [25], Kelcz [26]
d Meeuwis [27], Renz [28], Veltman [29]
1606 Eur Radiol (2011) 21:1600–1608evidenceofpublicationbiasandthereforeitisnotexpectedthat
the meta-analysis overestimates the effect of CAD evaluation.
The ten studies used different indications for breast MRI
and there was a wide variation in the number and tissue
type of lesions selected [20–29]. This resulted in the greater
heterogeneity. Therefore, we used a random-effects model
that interprets the results with more caution. Furthermore,
there was an indication of selection bias. In all studies the
radiologists only assessed MRIs with lesions (≥ BIRADS 2)
and discriminated between benign and malignant. This
selection increased the prevalence of breast malignancy in
the study population compared with the target population.
The lesion selection could have influenced the performance
of the radiologist.
Six studies analysed the influence of the presence or
absence of “threshold enhancement” at different minimum
thresholds. Of those six, the study by Meeuwis et al. [27]
resulted in the highest sensitivity and specificity. This result
could be explained by the fact that a 3.0T MRI system was
applied, which has a better performance than the 1.5T MRI
scanner which was used in the other studies.
With CADstream the sensitivity at a higher enhance-
ment threshold remained the same, i.e. the same
malignant lesions enhanced at the 50%, 80% and 100%
thresholds [20]. The remaining false-negative enhancing
malignant lesions showed no enhancement with CAD-
stream due to a noise filtering process leading to failure of
automatic analysis of small areas of enhancement [21, 27].
The specificity of CADstream increased at higher en-
hancement thresholds, which means that at a higher
threshold benign lesions did not enhance [20]. Therefore,
absence of lesion enhancement at higher thresholds helps
to improve the discrimination between benign and
malignant lesions. In comparison to the study by Meeuwis
et al. [27], the low specificity of the study by Williams et
al. [21] is most likely due to the high prevalence (n=22/71
versus n=113/154) and the large tissue type variation of
benign lesions.
With the DynaCAD software the specificity perfor-
mance was analogous to that of the CADstream software.
The sensitivity of DynaCAD however, decreased at
higher threshold enhancements, not visualising all ma-
lignant enhancements, resulting in false-negative lesions
[23].
Residents or radiologists with no or less experience
achieved a higher sensitivity when they were accompanied
by a CAD system for discrimination between breast lesions
on MRI. The change in sensitivity after using CAD was not
significant. Nevertheless, a considerable increase could be
seen (sensitivity from 72%; 95% CI: 62–81% to 89%; 95%
CI: 80–94%). This increase could be a result of the fact that
CAD brings more enhancing lesions to the attention of the
resident or inexperienced radiologist. Therefore, it seems
that they benefit from CAD when assessing breast lesions
with MRI. However, more research must be conducted to
verify these results.
The performance of the experienced radiologists showed
a non-significant decrease in specificity from 86% (95% CI:
79–91%) without CAD to 82% (95% CI: 76–87%) with
CAD. A clarification for this observation could be that
CAD systems are only based on the enhancement dynamic,
without regarding the morphology of the lesion. As a
consequence, the use of CAD could lead to a higher
number of enhancing lesions, part of which could be
assigned as benign on the basis of morphology. The
experienced radiologists can be mislead by the enhance-
ment pattern of CAD, resulting in a decrease in specificity.
Therefore, it is important that experienced radiologists are
aware of this.
In conclusion, concerning the assessment of MR images
CAD has little influence on the sensitivity and specificity of the
performance of radiologists experienced in breast MRI
diagnosis. Therefore, breast MRI interpretation by radiologists
remainsessential.Residentsorradiologistswithlessexperience
seem to benefit from a CAD system when performing breast
MRI evaluation.
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